CagriSema Titration (Cagrilintide + Semaglutide)
Investigational CagriSema combination reconstituted as a 16-week titration of cagrilintide and semaglutide dosed weekly.
Concentration over time
Protocol summary
CagriSema Titration (Cagrilintide + Semaglutide) · 16 weeks starting Jun 18, 26
- Semaglutide Injection (Ozempic/Wegovy) — 250 mcg Every 7 days, weeks 0–4
- Cagrilintide — 160 mcg Every 7 days, weeks 0–4
- Semaglutide Injection (Ozempic/Wegovy) — 500 mcg Every 7 days, weeks 5–8
- Cagrilintide — 300 mcg Every 7 days, weeks 5–8
- Semaglutide Injection (Ozempic/Wegovy) — 1.00 mg Every 7 days, weeks 9–12
- Cagrilintide — 600 mcg Every 7 days, weeks 9–12
- Semaglutide Injection (Ozempic/Wegovy) — 2.40 mg Every 7 days, weeks 13–16
- Cagrilintide — 2.40 mg Every 7 days, weeks 13–16
Compounds
Typical 250 mcg–2.40 mg · Every 7 days
Typical 160 mcg–2.40 mg · Every 7 days
Typical 250 mcg–2.40 mg · Every 7 days
Typical 160 mcg–2.40 mg · Every 7 days
Typical 250 mcg–2.40 mg · Every 7 days
Typical 160 mcg–2.40 mg · Every 7 days
Typical 250 mcg–2.40 mg · Every 7 days
Typical 160 mcg–2.40 mg · Every 7 days